These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 35368525)
21. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD; Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508 [TBL] [Abstract][Full Text] [Related]
22. Development of prediction model for osteoporotic vertebral compression fracture screening without using clinical risk factors, compared with FRAX and other previous models. Chanplakorn P; Lertudomphonwanit T; Daraphongsataporn N; Sritara C; Jaovisidha S; Sa-Ngasoongsong P Arch Osteoporos; 2021 Jun; 16(1):84. PubMed ID: 34085107 [TBL] [Abstract][Full Text] [Related]
23. Comparison of screening tools for optimizing fracture prevention in Canada. Leslie WD; Lix LM; Binkley N Arch Osteoporos; 2020 Oct; 15(1):170. PubMed ID: 33111193 [TBL] [Abstract][Full Text] [Related]
24. Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool. Lin J; Yang Y; Fei Q; Zhang X; Ma Z; Wang Q; Li J; Li D; Meng Q; Wang B Clin Interv Aging; 2016; 11():461-9. PubMed ID: 27217730 [TBL] [Abstract][Full Text] [Related]
25. The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease. Jamal SA; West SL; Nickolas TL Osteoporos Int; 2014 Jan; 25(1):71-6. PubMed ID: 24114399 [TBL] [Abstract][Full Text] [Related]
26. FRAX®: prediction of major osteoporotic fractures in women from the general population: the OPUS study. Briot K; Paternotte S; Kolta S; Eastell R; Felsenberg D; Reid DM; Glüer CC; Roux C PLoS One; 2013; 8(12):e83436. PubMed ID: 24386199 [TBL] [Abstract][Full Text] [Related]
27. Validation of the FRAX predictive model for major osteoporotic fracture in a historical cohort of Spanish women. Tebé Cordomí C; Del Río LM; Di Gregorio S; Casas L; Estrada MD; Kotzeva A; Espallargues M J Clin Densitom; 2013; 16(2):231-7. PubMed ID: 22748778 [TBL] [Abstract][Full Text] [Related]
28. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study. Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472 [TBL] [Abstract][Full Text] [Related]
29. [Risk factors for bone mineral density changes in patients with rheumatoid arthritis and fracture risk assessment]. Wang Y; Hao YJ; Deng XR; Li GT; Geng Y; Zhao J; Zhou W; Zhang ZL Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):781-6. PubMed ID: 26474615 [TBL] [Abstract][Full Text] [Related]
30. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability. McCloskey EV; Fitzpatrick LA; Hu MY; Williams G; Kanis JA Arch Osteoporos; 2019 Feb; 14(1):15. PubMed ID: 30719589 [TBL] [Abstract][Full Text] [Related]
31. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool. Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927 [TBL] [Abstract][Full Text] [Related]
32. Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program. Leslie WD; Aubry-Rozier B; Lix LM; Morin SN; Majumdar SR; Hans D Bone; 2014 Oct; 67():10-4. PubMed ID: 24998455 [TBL] [Abstract][Full Text] [Related]
33. FRAX and the effect of teriparatide on vertebral and non-vertebral fracture. Harvey NC; Kanis JA; Odén A; Burge RT; Mitlak BH; Johansson H; McCloskey EV Osteoporos Int; 2015 Nov; 26(11):2677-84. PubMed ID: 26092063 [TBL] [Abstract][Full Text] [Related]
34. Does osteoporosis therapy invalidate FRAX for fracture prediction? Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA; J Bone Miner Res; 2012 Jun; 27(6):1243-51. PubMed ID: 22392538 [TBL] [Abstract][Full Text] [Related]
35. The added value of trabecular bone score to FRAX® to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong. Su Y; Leung J; Hans D; Lamy O; Kwok T Osteoporos Int; 2017 Jan; 28(1):111-117. PubMed ID: 27565645 [TBL] [Abstract][Full Text] [Related]
36. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA; J Bone Miner Res; 2010 Nov; 25(11):2350-8. PubMed ID: 20499367 [TBL] [Abstract][Full Text] [Related]
37. FRAX underestimates fracture risk in patients with diabetes. Giangregorio LM; Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA J Bone Miner Res; 2012 Feb; 27(2):301-8. PubMed ID: 22052532 [TBL] [Abstract][Full Text] [Related]
38. DUAL-ENERGY X-RAY ABSORPTIOMETRY AND CALCULATED FRAX RISK SCORES MAY UNDERESTIMATE OSTEOPOROTIC FRACTURE RISK IN VITAMIN D-DEFICIENT VETERANS WITH HIV INFECTION. Stephens KI; Rubinsztain L; Payan J; Rentsch C; Rimland D; Tangpricha V Endocr Pract; 2016 Apr; 22(4):440-6. PubMed ID: 26684149 [TBL] [Abstract][Full Text] [Related]
39. A cross-sectional comparison of selected anthropometric, laboratory, and densitometric parameters in postmenopausal osteoporotic women with and without vertebral compression fractures. Sawicki P; Tałałaj M; Życińska K; Zgliczyński WS; Wierzba W Endokrynol Pol; 2021; 72(3):191-197. PubMed ID: 33619710 [TBL] [Abstract][Full Text] [Related]
40. Predictors of fracture risk and bone mineral density in men with prostate cancer on androgen deprivation therapy. Neubecker K; Adams-Huet B; Farukhi IM; Delapena RC; Gruntmanis U J Osteoporos; 2011; 2011():924595. PubMed ID: 21826255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]